نتایج جستجو برای: aggressive multimodality

تعداد نتایج: 63355  

2012
Benyam Yoseph Ming Chi Alexander M. Truskinovsky Arkadiusz Z. Dudek

Large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix is a rare and aggressive malignancy with poor prognosis even in its early stage, despite multimodality treatment strategy. Here, we report a case of a woman with clinical polypoid stage IB LCNEC of the cervix, which was detected in her 6-week postpartum checkup. A literature review was also conducted to evaluate current therapeut...

Journal: :Journal of Pragmatics 2021

This paper examines the ways in which speech act of complaint is realised social media contexts. To date, little attention has been devoted to realisation this online settings, despite fact that such settings provide different affordances for complaining than many their spoken and written counterparts. In current study, we aim make a step towards filling knowledge gap by demonstrating – particu...

Journal: :Current urology 2016
Sahil Gupta Kaustav Majumder Anurag Chahal Ashish K Saini Arjun Gupta

Primitive neuroectodermal tumors (PNET) are an aggressive group of small round cell tumors usually arising in the nervous system and affecting children. They have a tendency for local invasion, distant spread and formation of tumor thrombi. The kidney is a rare primary location for these tumors. Outcomes are frequently poor due to late diagnosis (Wilms tumor is a more common tumor in this popul...

2015
Yogesh Kumar Sarin Prince Raj

Wilms' tumor in the current era of multimodality treatment has promising outcome, but approximately 10-15% of the patients with favorable-histology, experience tumor progression or relapse. We hereby present an unusual case of repeated loco-regional recurrences in a patient with stage I intermediate-risk monophasic (epithelial variant) Wilms' tumor (WT) of pelvic kidney requiring aggressive the...

2014
Sergio Sartori Paola Tombesi Francesca Di Vece

17-20 October 2014 Paris, France 62th Annual Meeting JFR Journées Françaises de Radiologie http://jfr.radiologie.fr/ Liver metastases (LM) from neuroendocrine tumors (NET) occur with variable frequency depending on the primary disease, ranging from 5-10% for carcinoid to 75% for glucagonoma1. LM have a major impact on survival, and the relatively indolent nature of well-differentiated NET and t...

2014
Khairi Hedi

Introduction: Embryonal rhabdomyosarcoma (RMS) of the uterine cervix is a rare and extremely aggressive malignant entity. However, prognosis seems to be improved with the use of multimodality approach treatment. Cases: We report the cases of 50and 51-year-old women, presenting with vaginal bleeding and mass. The two patients underwent radical surgery. Histological examination revealed RMS of ut...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2000
D Giuffrida H Gharib

BACKGROUND Anaplastic thyroid carcinoma (ATC), accounting for 5% to 15% of primary malignant thyroid neoplasms, is one of the most aggressive solid tumors in humans. Generally, it is rapidly fatal, with a mean survival of six months after diagnosis. Multimodality treatment with surgery and/or external beam radiotherapy and chemotherapy are of fundamental importance for local control of disease ...

2016
Abdel-Ghani Azzouqa James P Stevenson

Malignant pleural mesothelioma is an uncommon and aggressive thoracic malignancy that is rarely curable, even when multimodality therapy is used. Systemic chemotherapy is the primary treatment for the majority of patients with this disease; however, surgical resection may benefit a subset of patients with early-stage disease. The surgical approach that offers the best outcomes remains an area o...

Journal: :Journal of hepato-biliary-pancreatic surgery 2003
Nicole M Chandler Jonathan J Canete Keith E Stuart Mark P Callery

Despite advancements in the field of surgical oncology, the diagnosis of pancreatic cancer still carries a grave and dismal prognosis. Surgery alone for adenocarcinoma of the pancreatic head or uncinate process has a median survival time of 12 months. These grim statistics have led many to study the effects of combined multimodality therapy in the fight against pancreatic cancer. The long recov...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید